Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran

Background: Hip, vertebral and wrist fractures are the most common consequences of osteoporosis. This study aimed at analyzing the cost-effectiveness of teriparatide (CinnoPar®), compared with alendronate and risedronate, in the treatment of women aged 60 and over with postmenopausal osteoporosis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebadi Fard Azar, Amir Ali, Rezapour, Aziz, Alipour, Vahid, Sarabi-Asiabar, Ali, Gray, Serajaddin, Mobinizadeh, Mohammadreza, Yousefvand, Mani, Arabloo, Jalal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804430/
https://www.ncbi.nlm.nih.gov/pubmed/29445668
http://dx.doi.org/10.14196/mjiri.31.39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804430/
https://www.ncbi.nlm.nih.gov/pubmed/29445668
http://dx.doi.org/10.14196/mjiri.31.39

Ejemplares similares